SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

OAK Oakridge International Limited

Healthcare · Health Information Services · website
$0.08
52wk 0.06 – 0.14
Overall
70.3
Value
69.2
Growth
100.0
Health
69.2
Quality
28.8
Momentum
75.0
Dividend
—
Price
About Oakridge International Limited

Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also engaged in the development of Internet of Things technology activities. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia.

Price analytics

Returns

1 day 0.0%
1 week 8.1%
1 month 31.1%
3 months 11.1%
6 months 23.1%
1 year -12.1%
3 years 6.7%

Risk

Volatility (1y ann.) 53.8%
Beta vs ASX 200 0.28
Sharpe (1y) -0.04
VaR 95% (1-day) -6.2%
Max drawdown (1y) -40.0%
Off 1-year high -20.0%

Technicals

RSI(14) 100 OB
vs 50DMA 14.3%
vs 200DMA 4.9%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 69.2
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
41
Price / Book
85
Price / Sales
100
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 28.8
Return on equity
48
Return on assets
43
Operating margin
0
Net margin
21
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 75.0
6-month return vs ASX 200
100
Price vs 200-day average
66
Price vs 50-day average
100
Position in 52-week range
24

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$2.56M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.33
EV / EBITDA
13.42
Price / Book
1.86
ROE
9.6%
Operating margin
-2.9%
Net margin
3.2%
Total cash
$637,641
Total debt
$95,454
Current ratio
2.61
Debt / Equity
0.07
Free cash flow
$-116,130
Avg volume
8,824
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$2.23M
  • Gross profit$1.12M
  • Operating income-$650.56K
  • Net income-$128.79K
  • Diluted EPS-0.00
  • Free cash flow-$395.68K
  • Net debt-$267.00K
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4